Traders worry vaccine complacency is the new risk to the market

UBS’ Art Cashin believes the market may be far too complacent in believing that a highly effective vaccine is imminent.UBS’ Art Cashin believes the market may be far too complacent in believing that a highly effective vaccine is imminent.